GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kindred Healthcare Inc (NYSE:KND) » Definitions » Beneish M-Score

Kindred Healthcare (Kindred Healthcare) Beneish M-Score : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kindred Healthcare Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Kindred Healthcare's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Kindred Healthcare was 0.00. The lowest was 0.00. And the median was 0.00.


Kindred Healthcare Beneish M-Score Historical Data

The historical data trend for Kindred Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindred Healthcare Beneish M-Score Chart

Kindred Healthcare Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.16 -2.51 -2.10 -2.88 -3.01

Kindred Healthcare Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.12 -3.43 -3.16 -3.01 -2.82

Competitive Comparison of Kindred Healthcare's Beneish M-Score

For the Medical Care Facilities subindustry, Kindred Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindred Healthcare's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kindred Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Kindred Healthcare's Beneish M-Score falls into.



Kindred Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Kindred Healthcare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9654+0.528 * 0.9974+0.404 * 0.9787+0.892 * 0.9647+0.115 * 1.1524
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0245+4.679 * -0.051172-0.327 * 1.1265
=-2.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar18) TTM:Last Year (Mar17) TTM:
Total Receivables was $1,169 Mil.
Revenue was 1513.789 + 1483.282 + 1477.141 + 1532.022 = $6,006 Mil.
Gross Profit was 1513.789 + 595.777 + 573.239 + 620.535 = $3,303 Mil.
Total Current Assets was $1,400 Mil.
Total Assets was $5,206 Mil.
Property, Plant and Equipment(Net PPE) was $726 Mil.
Depreciation, Depletion and Amortization(DDA) was $107 Mil.
Selling, General, & Admin. Expense(SGA) was $2,195 Mil.
Total Current Liabilities was $809 Mil.
Long-Term Debt & Capital Lease Obligation was $3,266 Mil.
Net Income was -1.705 + -187.7 + -95.786 + -409.118 = $-694 Mil.
Non Operating Income was -7.305 + -300.994 + -19.157 + -136.364 = $-464 Mil.
Cash Flow from Operations was -132.403 + 67.183 + 8.481 + 92.669 = $36 Mil.
Total Receivables was $1,255 Mil.
Revenue was 1539.49 + 1517.716 + 1563.276 + 1605.374 = $6,226 Mil.
Gross Profit was 1539.49 + 592.098 + 610.196 + 673.383 = $3,415 Mil.
Total Current Assets was $1,574 Mil.
Total Assets was $6,145 Mil.
Property, Plant and Equipment(Net PPE) was $856 Mil.
Depreciation, Depletion and Amortization(DDA) was $149 Mil.
Selling, General, & Admin. Expense(SGA) was $2,221 Mil.
Total Current Liabilities was $925 Mil.
Long-Term Debt & Capital Lease Obligation was $3,345 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1168.506 / 6006.234) / (1254.631 / 6225.856)
=0.194549 / 0.201519
=0.9654

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3415.167 / 6225.856) / (3303.34 / 6006.234)
=0.548546 / 0.549985
=0.9974

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1400.072 + 725.519) / 5206.363) / (1 - (1574.016 + 855.542) / 6144.609)
=0.591732 / 0.604603
=0.9787

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6006.234 / 6225.856
=0.9647

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(148.676 / (148.676 + 855.542)) / (106.947 / (106.947 + 725.519))
=0.148052 / 0.12847
=1.1524

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2195.493 / 6006.234) / (2221.315 / 6225.856)
=0.365536 / 0.356789
=1.0245

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3266.364 + 808.69) / 5206.363) / ((3344.511 + 924.725) / 6144.609)
=0.782706 / 0.694794
=1.1265

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-694.309 - -463.82 - 35.93) / 5206.363
=-0.051172

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Kindred Healthcare has a M-score of -2.82 suggests that the company is unlikely to be a manipulator.


Kindred Healthcare Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Kindred Healthcare's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindred Healthcare (Kindred Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
Kindred Healthcare Inc is a healthcare-services company in the United States that operates in four divisions: hospitals, Kindred at Home, Kindred Rehabilitation Services, and nursing centers. The hospital division provides long-term acute-care services through a network of transitional-care hospitals. The Kindred at Home division provides home health and hospice care for patients in their homes, nursing centers, and other residential settings. This segment contributes the majority of the firm's total revenue. The Rehabilitation Services division provides physical and occupational therapy to residents of nursing centers, hospitals, outpatient clinics, and assisted living facilities. Kindred's nursing center division operates nursing centers and assisted-care facilities.
Executives
Heyward R Donigan director 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Phyllis R Yale director
Paul J Diaz director 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Joel Ackerman director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Richard Goodman director PEPSICO, INC., 700 ANDERSON HILL ROAD, PURCHASE NY 10577
Christopher T Hjelm director C/O THE KROGER CO., 1014 VINE ST., CINCINNATI OH 45202
Stephen D Farber officer: EVP & Chief Financial Officer 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Jonathan David Blum director C/O YUM BRANDS INC, 1441 GARDINER LANE, LOUISVILLE KY 40213
Lynn T Simon director 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067
Fred J Kleisner director C/O MORGANS HOTEL GROUP CO., 475 TENTH AVENUE, NEW YORK NY 10018
Sharad Mansukani director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Thomas P Cooper director PO BOX 3335, SANTA FE CA 92067
John H Short director 7733 FORSYTH BLVD.,, SUITE 2300, ST. LOUIS MO 63105
Edward L Kuntz director, other: Chairman of the Board
Richard A Lechleiter officer: Executive VP and CFO PO BOX 32890, LOUISVILLE KY 40232-2890